Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ian Pyman Insider Profile
4 Followers
Ian Pyman, Director at Prescient Therapeutics Limited, holds 7.57M shares in Prescient Therapeutics Limited (Ticker: PSTTF).
Ian Pyman Prescient Therapeutics Limited (PSTTF)Director
Prescient Therapeutics Limited (PSTTF)
Director
Not Ranked
Ian Pyman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Ian Pyman does not currently own shares as a corporate insider.
A breakdown of Ian Pyman's holdings
Insider Roles
Ian Pyman does not currently hold a role as a corporate insider.
Roles that Ian Pyman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ian Pyman
Ian Pyman's Trading History
List of latest transactions for each holding click on a transaction to see Ian Pyman's performance on stock
You May Also Like
Ian Pyman insider profile FAQ
What is the percentage of profitable transactions made by Ian Pyman?
The percentage of profitable transactions made by Ian Pyman is ―.
What is the average return per transaction made by Ian Pyman?
The average return per transaction made by Ian Pyman is ―.
What stocks does Ian Pyman hold?
Ian Pyman holds: PSTTF stocks.
What was Ian Pyman’s latest transaction?
Ian Pyman latest transaction was an Uninformative Buy of $29.96K.
What was Ian Pyman's most profitable transaction?
Ian Pyman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ian Pyman's role in Prescient Therapeutics Limited?
Ian Pyman's role in Prescient Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.